Skip to main content
. 1998 Oct 24;317(7166):1125–1130. doi: 10.1136/bmj.317.7166.1125

Table 5.

Proportions recommended for active lipid lowering treatment by the different guidelines. Percentages for 25-64 years are directly age standardised to 1991 population of England and Wales

Guidelines Men
Women
Age 25-44 (n=128)
Age 45-64 (n=194)
Age 25-64 (n=322)
Age 25-44 (n=112)
Age 45-64 (n=207)
Age 25-64 (n=319)
No % (95% CI) No % (95% CI) No % (95% CI) No % (95% CI) No % (95% CI) No % (95% CI)
British Hyperlipidaemia Association  2 1.6 (0.1 to 5.5)   18 9.3 (5.2 to 13.4)  20 4.6 (2.3 to 6.9)  1 0.9 (0 to 4.9)   13 6.3 (3.0 to 9.6)  14 2.8 (1.0 to 4.6)  
Drugs and Therapeutics Bulletin  2 1.6 (0.1 to 5.5)   23 11.9 (7.3 to 16.5)   25 5.3 (2.9 to 7.7)  1 0.9 (0 to 4.9)   16 7.7 (4.1 to 11.3) 17 3.3 (1.3 to 5.3)  
European Atherosclerosis Association:
 Possible drug treatment*  1 0.8 (0 to 4.3)    20 10.3 (6.0 to 14.6)   21 5.0 (2.9 to 7.9)  1 0.9 (0 to 4.9)   20 9.7 (6.0 to 14.5) 21 4.5 (2.4 to 7.3) 
 Intensive dietary measures only  8 6.3 (2.7 to 11.9)  74 38.1 (31.3 to 45.0)  82 18.0 (13.8 to 22.2) 1 0.9 (0 to 4.9)   31 15.0 (10.1 to 19.8) 32 6.0 (3.6 to 9.2) 
 All  9 7.0 (3.3 to 12.9)  94 48.5 (41.4 to 55.5) 103 23.0 (18.4 to 27.6) 2 1.8 (0.2 to 6.3)  51 24.6 (18.8 to 30.5) 52 10.6 (7.3 to 14.0) 
National cholesterol education program:
 Possible drug treatment* 13 10.2 (4.9 to 15.4)   55 28.4 (22.0 to 34.7)  68 17.5 (13.3 to 21.5) 2 1.8 (0.2 to 6.3)  47 22.7 (17.0 to 28.4) 49 9.5 (6.4 to 13.2)
 Intensive dietary measures only 21 16.4 (10.0 to 22.8)  48 24.7 (18.7 to 30.8)  69 19.7 (15.2 to 23.9) 7 6.3 (2.6 to 12.5) 48 23.2 (17.4 to 28.9) 55 12.7 (9.2 to 16.5) 
 All 34 26.6 (18.9 to 34.3) 103 53.1 (46.1 to 60.1) 137 37.2 (31.9 to 42.5) 9 8.0 (3.0 to 13.0) 95 45.9 (39.1 to 52.7) 104 22.2 (17.6 to 26.8)
*

If intensive dietary measures fail to lower cholesterol to target values.